Recruitment

The company was founded in 2016 with a registered capital of RMB 16153846.The shareholders of the company are:Hainan ruikewei Pharmaceutical Co.,Ltd.holds 60%,and Nanjing Hairong Pharmaceutical Technology Co.,Ltd.holds 40%.An innovative pharmaceutical platform enterprise committed to drug R&D and industrialization,mainly focusing on the drugs used in core cardiology examination.Based on the principle of"drug marketing license holder"system and considering the characteristics of long cycle and high risk in the process of drug research and development to marketing,the company is specially established to accelerate the industrialization of drug research and development and achieve the purpose of risk sharing and benefit sharing.
瑞克卫质量投诉电话:13303115272 邮箱:rm@recovery-medica.com